Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
Starting soon · Not applicable
Conditions studied: Cervical Cancer, HIV
In brief
All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Key facts
- Study ID
- NCT06850402
- Run by
- M.D. Anderson Cancer Center
- People needed
- 400
- Starts
- 2026-06-01
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-03-09
Who can join
Age: 25 and older, up to 49. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women aged 25 - 49 years
- women undergoing cervical biopsy and/or LEEP
- Women who are not pregnant and with a negative pregnancy test (within 3 days of enrollment)
- Willing and capable of providing informed consent
You may not qualify if…
- Women under 25 or over 49 years of age
- Women not undergoing cervical biopsy or LEEP
- Women who are pregnant
Where it is running
- The University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.